Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5‐HT1A Signalling

Documenti analoghi

• Investigation of Novel Isatinylhydantoin Derivatives as Potential Anti‐Kinetoplastid Agents
  di: Keamogetswe Sechoaro, et al.
  Pubblicazione: (2024)
• Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
  di: Isabelle Lyothier, et al.
  Pubblicazione: (2025)
• Development of New Benzo[ b ]Thiophene‐2‐Carboxamide Derivatives as Advanced Glycation End‐Products Receptor (RAGE) Antagonists
  di: Lisa Bonin, et al.
  Pubblicazione: (2025)
• Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
  di: Agata Zięba, et al.
  Pubblicazione: (2024)
• Identification of Novel and Selective GPR39 Receptor Antagonists for the Treatment of Acute Myocardial Ischemia
  di: Agostino Cianciulli, et al.
  Pubblicazione: (2025)